Redhill Biopharma Ltd (RDHL) — Long-term Investment Intensity
Redhill Biopharma Ltd (RDHL) has a Long-term Investment Intensity of 47.5% as of December 2025. Long-term investments of $12.05 Million represent 47.5% of total assets of $25.34 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check RDHL capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Redhill Biopharma Ltd Long-term Investment Intensity (2013–2025)
This chart shows how Redhill Biopharma Ltd's Long-term Investment Intensity has evolved across 8 annual periods from 2013 to 2025. As of December 2025, the intensity stands at 47.5%, reflecting long-term investments of $12.05 Million against total assets of $25.34 Million USD. Explore RDHL cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Redhill Biopharma Ltd (2013–2025)
The table below presents the year-by-year Long-term Investment Intensity for Redhill Biopharma Ltd from 2013 to 2025, covering 8 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Redhill Biopharma Ltd market cap and net worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 47.5% | $12.05 Million | $25.34 Million | ▲ +47.3 pp |
| 2019 | 0.2% | $152.00K | $74.10 Million | ▼ 0.0 pp |
| 2018 | 0.2% | $140.00K | $62.41 Million | ▼ 0.0 pp |
| 2017 | 0.3% | $152.00K | $57.34 Million | ▲ +0.1 pp |
| 2016 | 0.2% | $137.00K | $74.21 Million | ▼ 0.0 pp |
| 2015 | 0.2% | $134.00K | $66.83 Million | ▼ -0.1 pp |
| 2014 | 0.3% | $76.00K | $28.86 Million | ▼ -0.3 pp |
| 2013 | 0.6% | $81.00K | $14.34 Million | — |